Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly EBT Margin of 1.49% for Q1 2026, down 989.0% year-over-year from 0.17% in Q1 2025, and down 83.97% quarter-over-quarter from 9.26% in Q4 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' EBT Margin history runs 17 years deep, the most recent figure standing at 1.49% for Q1 2026.
- In Q1 2026, EBT Margin fell 989.0% year-over-year to 1.49%; the TTM figure through Mar 2026 stood at 10.51% (down 1608.0% YoY), while the FY2025 annual figure was 12.96%, down 1398.0% from the prior year.
- EBT Margin for Q1 2026 stood at 1.49%, down from 9.26% in the prior quarter.
- The five-year high for EBT Margin was 62.05% in Q4 2024, with the low at 97.49% in Q1 2022.
- The 5-year median for EBT Margin is 9.26% (2025), against an average of 3.39%.
- The sharpest annual moves came in 2023 and 2025: EBT Margin soared 5959 bps in 2023, then sank 5278 bps in 2025.
- Acadia Pharmaceuticals' EBT Margin stood at 29.92% in 2022, then jumped by 157 bps to 17.17% in 2023, then jumped by 261 bps to 62.05% in 2024, then tumbled by 85 bps to 9.26% in 2025, then slumped by 84 bps to 1.49% in 2026.
- Business Quant data shows ACAD's EBT Margin at 1.49% in Q1 2026, 9.26% in Q4 2025, and 16.0% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Acadia Pharmaceuticals | 4.82 Bn | 3.86 Bn | 279.64 Mn | 15.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.10% |
| Mar 31, 2026 | 1.49% |
| Dec 31, 2025 | 9.26% |
| Sep 30, 2025 | 16.01% |
| Jun 30, 2025 | 15.20% |
| Mar 31, 2025 | 11.38% |
| Dec 31, 2024 | 62.05% |
| Sep 30, 2024 | 15.50% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | 10.20% |
| Dec 31, 2023 | 17.18% |
| Sep 30, 2023 | -24.63% |
| Jun 30, 2023 | 3.84% |
| Mar 31, 2023 | -37.94% |
| Dec 31, 2022 | -29.92% |
| Sep 30, 2022 | -20.21% |
| Jun 30, 2022 | -24.97% |
| Mar 31, 2022 | -97.52% |
| Dec 31, 2021 | -32.81% |
| Sep 30, 2021 | -11.24% |